243 related articles for article (PubMed ID: 32500575)
1. Non-invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas.
Calle C; Kuba MG; Brogi E
Breast J; 2020 Jun; 26(6):1148-1155. PubMed ID: 32500575
[TBL] [Abstract][Full Text] [Related]
2. The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS.
Brogi E
Virchows Arch; 2022 Dec; 481(6):823-837. PubMed ID: 35567633
[TBL] [Abstract][Full Text] [Related]
3. Upgrade Rates of Pure, Radiology-Pathology Concordant Lobular Neoplasia Diagnosed on Breast Core Needle Biopsy: Is Surgical Excision Warranted?
Karimi Z; Phillips J; Brook A; Baker G; Guzman Y; Mehta TS
Acad Radiol; 2022 Jul; 29(7):1029-1038. PubMed ID: 34702673
[TBL] [Abstract][Full Text] [Related]
4. Management of Lobular Neoplasia Diagnosed by Core Biopsy.
Jani C; Lotz M; Keates S; Gupta Y; Walker A; Al Omari O; Parvez A; Patel D; Gnata M; Perry J; Khorashadi L; Weissmann L; Pories SE
Breast J; 2023; 2023():8185446. PubMed ID: 37114120
[TBL] [Abstract][Full Text] [Related]
5. When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted.
Fives C; O'Neill CJ; Murphy R; Corrigan MA; O'Sullivan MJ; Feeley L; Bennett MW; O'Connell F; Browne TJ
Breast; 2016 Dec; 30():125-129. PubMed ID: 27718416
[TBL] [Abstract][Full Text] [Related]
6. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.
Sen LQ; Berg WA; Hooley RJ; Carter GJ; Desouki MM; Sumkin JH
AJR Am J Roentgenol; 2016 Nov; 207(5):1132-1145. PubMed ID: 27532153
[TBL] [Abstract][Full Text] [Related]
7. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
Elsheikh TM; Silverman JF
Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
[TBL] [Abstract][Full Text] [Related]
8. Management of screening-detected lobular neoplasia in the era of digital breast tomosynthesis: A preliminary study.
Gao Y; Bahl M
Clin Imaging; 2023 Nov; 103():109979. PubMed ID: 37673705
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center.
Shamir ER; Chen YY; Chu T; Pekmezci M; Rabban JT; Krings G
Am J Surg Pathol; 2019 Mar; 43(3):399-408. PubMed ID: 30489319
[TBL] [Abstract][Full Text] [Related]
10. Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases.
Susnik B; Day D; Abeln E; Bowman T; Krueger J; Swenson KK; Tsai ML; Bretzke ML; Lillemoe TJ
Clin Breast Cancer; 2016 Dec; 16(6):507-513. PubMed ID: 27425222
[TBL] [Abstract][Full Text] [Related]
11. Risk for Upgrade to Malignancy After Breast Core Needle Biopsy Diagnosis of Lobular Neoplasia: A Systematic Review and Meta-Analysis.
Shehata MN; Rahbar H; Flanagan MR; Kilgore MR; Lee CI; Ryser MD; Lowry KP
J Am Coll Radiol; 2020 Oct; 17(10):1207-1219. PubMed ID: 32861602
[TBL] [Abstract][Full Text] [Related]
12. Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.
Kuba MG; Murray MP; Coffey K; Calle C; Morrow M; Brogi E
Mod Pathol; 2021 Aug; 34(8):1495-1506. PubMed ID: 33824462
[TBL] [Abstract][Full Text] [Related]
13. Descriptive study comparing outcomes of classic and nonclassic lobular carcinoma in situ (florid and pleomorphic) initially diagnosed on core needle biopsy.
Singh K; Sung CJ; Quddus MR
Breast J; 2020 Dec; 26(12):2350-2356. PubMed ID: 33047861
[TBL] [Abstract][Full Text] [Related]
14. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
15. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy.
Shin SJ; Rosen PP
Arch Pathol Lab Med; 2002 Jun; 126(6):697-701. PubMed ID: 12033958
[TBL] [Abstract][Full Text] [Related]
16. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
Berg WA; Mrose HE; Ioffe OB
Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
[TBL] [Abstract][Full Text] [Related]
18. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
[TBL] [Abstract][Full Text] [Related]
19. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.
Sullivan ME; Khan SA; Sullu Y; Schiller C; Susnik B
Arch Pathol Lab Med; 2010 Jul; 134(7):1024-8. PubMed ID: 20586632
[TBL] [Abstract][Full Text] [Related]
20. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
Lewis JL; Lee DY; Tartter PI
Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
